# GLP-1 weight loss and muscle: what deserves attention

Weight loss can include lean tissue as well as fat. Nutrition, strength training and changes in everyday function all matter during treatment.

Canonical: https://velri.co/blog/glp1-muscle-loss-question-plus-size-mom-before-first-injection
Publisher: Velri (https://velri.co/about)
Published: 2026-07-06
Updated: 2026-09-30
Editorial policy: https://velri.co/editorial-policy

Weight loss with a GLP-1 medication can include lean tissue as well as fat. The approved semaglutide label reports greater fat-mass loss than lean-mass loss; it does not promise that all the weight lost will be fat. [1]

## Lean mass and muscle are not interchangeable

A body-composition scan separates fat, lean tissue and bone mineral measurements. Lean tissue includes more than skeletal muscle, so a reported decline in lean mass should not be described as the exact amount of muscle lost. [2][3]

The practical question is also functional: has walking, climbing stairs, carrying groceries or getting out of a chair become harder? These details give a provider information that a weight reading cannot supply.

## Eating less still requires adequate nutrition

Reduced appetite can make it harder to eat enough protein and other nutrients. A joint advisory from nutrition and obesity medical societies recommends assessing usual food intake, strength and function alongside weight. It emphasizes appropriate nutrition and resistance exercise during treatment. [2]

An individual plan needs to account for existing health conditions, food preferences, physical ability and access to suitable meals.

For someone already training, a short account of usual exercises and any recent loss of performance can help describe the starting point. Someone who does not train can use ordinary activities as examples instead.

## Monitor the goal that matters to daily life

A follow-up can consider whether weight is changing, whether food intake remains adequate and whether activity is becoming easier or harder. Where a body-composition scan is used, changes need to be interpreted with the equipment and measurement conditions in mind. [2][3]

A useful goal is specific: continuing to carry a child comfortably, maintaining a familiar exercise or improving walking tolerance.

## Sources
[1] DailyMed - WEGOVY- semaglutide injection, solution
WEGOVY- semaglutide tablet. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
[2] 
            Nutritional Priorities to Support GLP-1 Therapy for Obesity: A Joint Advisory From the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society - PMC
        . https://pmc.ncbi.nlm.nih.gov/articles/PMC12125019/
[3] Text Official Adult Positions - ISCD. https://iscd.org/text-based-official-adult-positions/

## About this information
General health information, not personal medical advice, diagnosis or treatment. A prescription is required and is never guaranteed.
Velri is a brand operated by Velri Management LLC, a Nevada limited liability company. Velri is a non-clinical technology and administrative services company. Velri does not provide medical advice, diagnosis, treatment, or pharmacy services, and does not direct the clinical judgment of any provider.
All medical consultations and prescriptions are provided directly by independent provider groups (Online Medical Care, P.C.; TMD of Kansas, P.A.; TMD of Texas, P.A.; and TMD of CA, PC), by a provider licensed in your state. Velri does not employ providers. A prescription is issued only if a provider determines it is clinically appropriate in their independent medical judgment.
All prescription products are dispensed by independent, licensed pharmacies. Velri does not own, operate, or control any pharmacy and does not dispense medication. You may opt out of using a given provider group or pharmacy at any time.
Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
Velri is cash-pay. We do not bill Medicare, Medicaid, or commercial insurance. Refunds and order problems are addressed in the Terms of Use; your rights under applicable law are not limited. State availability and clinical eligibility apply.
Velri and telehealth are not for medical emergencies. If you are experiencing an emergency, call 911.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Care is available to eligible adults 18 and older in 47 states and D.C., United States only.
Notice of Privacy Practices: https://velri.co/privacy/notice-of-privacy-practices
Terms: https://velri.co/legal/terms
Provider group or pharmacy opt-out help: https://velri.co/contact and https://velri.co/standards#trust-support